Antioxidant dietary status and genetic cardiovascular risk, or how an adequate intake of a-tocopherol, selenium, taurine, magnesium and various other natural antioxidants may overcome the deleterious metabolic consequences related to the E4-4 type of apolipoprotein E

Magnes Res. 1996 Jun;9(2):139-41.
No abstract available

Publication types

  • Review

MeSH terms

  • Antioxidants / pharmacology*
  • Apolipoprotein E4
  • Apolipoproteins E / drug effects
  • Apolipoproteins E / genetics*
  • Apolipoproteins E / metabolism*
  • Arteriosclerosis / drug therapy
  • Arteriosclerosis / epidemiology
  • Arteriosclerosis / genetics
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / genetics*
  • Diet
  • Finland
  • Humans
  • Magnesium / pharmacology*
  • Norway
  • Taurine / pharmacology
  • Vitamin E / pharmacology

Substances

  • Antioxidants
  • Apolipoprotein E4
  • Apolipoproteins E
  • Vitamin E
  • Taurine
  • Magnesium